original contributions C825T GNB3 and Cerebrovascular Events the Atherosclerosis Risk in Communities database, suggested a mild association between the 825T allele and clinical stroke after adjustment for a small number of confounders. The second 21 and the third 22 were simple case-control studies based on descriptive statistics, whose structure and protocol did not allow any perspective analysis or inference to general population; in these studies, no association 21 or a modest association 22 between the GNB3 C825T polymorphism and CE was found. GNB3 is therefore a putative candidate gene for the risk of CE, but whether 825T-allele carriers are at increased risk for CE remains controversial 23 and needs to be confirmed in population-based setting. 9 We used a 10-year prospective study representative of general population to look for possible association between the C825T polymorphism of GNB3 gene and the risk of CE at a population level.
Methods
Study population. The Last Evidences Of Genetic Risk factors in the Aged (LEOGRA) population-based study was previously described in details elsewhere. [24] [25] [26] [27] [28] [29] In brief, all men and women aged ≥18 years living in two Italian towns (Torrebelvicino and Valli del Pasubio) were invited by letter; 1,678 of them (76%) gave informed consent and were recruited. The general characteristics of subjects who refused to participate were not different from those of subjects who accepted to participate in the study (data not shown).
Determination of phenotype. All subjects were invited to attend an initial screening and periodic medical visits at a special hospital unit and regularly followed up for 10 years or until death by a staff of specialists. At each visit, they received a Rose's questionnaire concerning lifestyle, smoking and drinking habits, nutrition, physical activity, quality of life, medication, personal and familial medical history. Blood pressure was measured in triplicate by trained medical doctors by means of an automatic 705 IT device (Omron Europe, Hoofddorp, Netherlands) and the average of the last two measurements was taken into account for the analysis of data.
Body height and weight were recorded without shoes with the subjects wearing light indoor clothing. Body mass index was computed as weight divided by squared height (in kg/m 2 ). The waist-to-hip ratio of the smallest circumference at the waist to the largest circumference at the hip level was calculated. Subscapular, suprailiac, and triceps skinfold thickness were measured at the right side of the body to the nearest 0.1 mm with a skinfold calliper (Harpenden, Bedfordshire, UK) providing a constant pressure of 0.01 kg/mm 2 (0.098 N/mm 2 ) ± 10% at all openings of the 90 mm 2 anvils.
Venous blood samples were taken at fast in the morning for determination of glucose, total cholesterol, high-density lipoprotein fraction, triglycerides, and uric acid. Low-density lipoprotein cholesterol was calculated through the formula of Friedewald. 30 As a measure of insulin resistance, the homeostasis model assessment index 31 was calculated from homeostasis assessment model (HOMA) = (circulating insulin in µU/ml) × (fasting blood glucose in mmol/l)/22.5. Menopausal status was determined in women by a detailed questionnaire asking for the age of cessation of menses. 32 Daily alcohol intake was calculated in grams ethanol from a detailed questionnaire asking for daily consumption of wine (ethanol 10-12%), beer (ethanol 3-7%), aperitifs (16-24%), and spirits (ethanol 33-46%). Categories and diseases were defined as described in Table 1 .
Echocardiographic left ventricular end-diastolic dimensions were used to compute left ventricular mass by an anatomically validated formula. 33 The mass was then indexed to body surface area. 34 For statistical analysis, the measurements of three cardiac cycles were averaged.
Historical CE were diagnosed in the presence of neurological signs, or positive history of stroke or transient ischemic attack, or positive computed tomography or magnetic resonance, or hospital discharge with Diagnosis-Related Group 430-438.
Determination of genotype. 28, 35 Genomic DNA was isolated from whole blood collected in ethylenediaminetetracetic acid tubes using a blood DNA Prep Plus spin-column system (A&A Biotechnology, Gdansk, Poland). For the determination original contributions
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Determination of outcome. Mortality was monitored through the Italian Register's Office and double-checked for causes of death by referring to hospitals, retirement homes or physicians' files. No cause of death was missing. Morbidity was monitored both through Diagnosis-Related Groups and referring to retirement homes and files of family doctors.
Subjects were labeled as having an incident CE when showing during the follow-up neurological signs of stroke or transient ischemic attack, or a positive computer tomography or magnetic resonance, or hospital discharge with DiagnosisRelated Group 430-438 not present at baseline screening. CE were labeled as fatal when followed by death.
Statistical analysis. The SAS package version 8.2 (SAS Institute, Cary, NC) was used for statistical analysis.
According to power analysis based on the results from previous studies of our staff, 28 the number of subjects resulted to be largely adequate.
Normal distribution of data was examined by the Kolmogorov-Smirnov normality test. Continuous variables were expressed as mean and s.d. To examine the agreement of the C825T GNB3 genotype frequency, Hardy-Weinberg equilibrium and allele frequencies were evaluated by χ 2 statistics. The null hypothesis was rejected for values of P < 0.05.
Subjects were divided into three groups according to the C825T polymorphism of GNB3 gene (CC, CT, and TT), and the groups were compared using analysis of variance for continuous variables and χ 2 test for categorical variables. According to previous experience of our group, 28 subjects were also stratified into C-carriers (CC + CT) and TT, and this stratification was used as a variable in analysis of variance and as a covariate in all logistic analyses.
Subjects having total serum cholesterol ≥200 mg/dl or triglycerides ≥150 mg/dl were labeled as dyslipidemic; those with diabetes + hypertension, diabetes + hypertension + dyslipidemia, and diabetes + hypertension + dyslipidaemia + obesity, respectively, were identified and separately examined in sensitivity analysis across the C825T polymorphism to look for possible clusters of risk factors.
Kaplan-Meier curves were generated after stratifying subjects into those who were C-carriers and those who carried the TT genotype.
Cox proportional hazard regression models were used to find the items, if any, having a prognostic role on incidence of events (<0.10 to enter and remove) and to generate the hazard ratios with 95% confidence intervals; the dummy variable «0 = C-carrier, 1 = TT» was used as factor for this purpose. For incident CE the follow-up time interval was defined as the time between the initial screening and the date of the first original contributions C825T GNB3 and Cerebrovascular Events event, for subjects not having incident CE the follow-up continued until the end of the study, the date of death, or the date of last contact if lost to follow-up, whichever came first. Four models were used for Cox analysis. Model 1 was only adjusted for age (years) and sex (0: women; 1: male). Model 2 was further adjusted for diabetes mellitus (0: absent; 1: present), smoking habits (yes, no), systolic and diastolic blood pressure (mm Hg), platelet count (cells/μl), waist-to-hip ratio, triceps skinfold thickness (mm), low-density lipoprotein serum cholesterol levels (mg/dl), serum triglycerides (mg/dl), serum uric acid (mg/dl), caffeine (mg/day), calories (kcal/day) and ethanol intake (g/day). Model 3 was further adjusted for coronary artery disease at baseline, and model 4 further adjusted for the number of historical CE. HOMA was also used in models 2, 3 and 4 instead of diabetes.
Ethics. The investigation described herein conforms with the principles outlined in the Declaration of Helsinki and with institutional guidelines, and was approved by the ethics committee of the University of Padova and by that of the Local Health Unit No. 4 of the Veneto Region. Before the study and after consulting his/her own general practitioner, each subject accepted and signed an informed consent.
results
In the whole cohort, mean age was 57.1 ± 18.3 years (range 18-94) and proportion of men 44.3%. The frequencies of the C and T alleles were 67.3 and 32.7%, respectively, similarly to those previously described in other Caucasians. 35, 36 The CC, CT, and TT genotypes were found in 43.4% (n = 728), 45.2% (n = 759), and 11.4% (n = 191), respectively, of the study population. These frequencies were in agreement with those predicted by the Hardy-Weinberg equilibrium (P = 0.67).
The general characteristics of the cohort across the C825T genotype are shown in Table 2 . When the C-carriers were compared to the TT subjects, no difference was detected apart from triceps skinfold thickness and prevalence of historical coronary events that were significantly higher in the latter than in the former. No cluster of risk factors was detected across the genotype ( Table 3) .
During the follow-up there were 73 nonfatal and 30 fatal CE, and 12 fatal cerebrovascular recurrences, whose distribution across the C825T polymorphism is summarized in Table 4 . This table also shows coronary events and episodes of acute heart failure.
Kaplan-Meier curves for survival free of CE are shown in Figure 1 . A divergence between TT subjects and C-carriers was observed starting from the 4th year of follow-up for fatal events and from the 3rd year of follow-up for nonfatal events.
In Cox analysis performed according to model 1, adjusted for age and sex only, the 825T allele directly and significantly predicted the incidence of fatal, nonfatal, and overall CE with a hazard ratio always greater than 2 ( Table 5) . Further adjustment for confounding covariables (model 2) and also for history of coronary artery disease (model 3) did not reduce the predictive value of the TT genotype, while further adjustment for historical CE (model 4) made the association between this genotype and fatal CE less significant (P = 0.06). Using HOMA instead of diabetes or arterial hypertension instead of systolic In the present analysis based on a 10-year longitudinal population-based study, the 825T homozygosis of GNB3 gene was associated with higher risk of incident CE. At univariate analysis, new cases of CE were more frequent in TT than in subjects who were CC, CT or C-carriers. This difference became evident from the 4th year of follow-up for fatal events and from the 3rd year of follow-up for nonfatal events. At multivariate Cox analysis fatal, nonfatal and overall CE and fatal recurrences were logistically predicted by the TT genotype. This association was independent of blood pressure and of other established risk factors for CE such as serum lipids, platelets, smoking, and ethanol intake. Our data therefore confirm, at a population level, the findings by Morrison et al. who found in a case/ control study a modest association between the 825T allele and incident stroke, 9 and those of the The Nord-Trøndelag Health Study on a cohort of hypertensive patients where increased cardiovascular risk was associated to the TT genotype independently of systolic blood pressure and other risk factors. 37, 38 Due to paucity of information, the reason why the TT polymorphism predisposes general population to CE while the C allele is protective in this respect can only be object of speculation. Both animal and human studies indicated that the risk of CE depends not only on blood pressure but also on genetic factors. 9, 39, 40 Despite comparable blood pressure levels, spontaneously hypertensive and stroke-prone-spontaneously hypertensive rats have different predisposition to stroke, suggesting the existence of blood pressure-independent risk factors, 39 and a predisposition to stroke has been found in Caucasian 9 but not in African 10 or Asian 41 people carrying the T allele, suggesting an individual racial/genetic interaction. In the here described study performed in a Caucasian general population the genetic predisposition to CE driven by the TT polymorphism was not mediated by blood pressure, obesity or other risk factors, as (i) these items were not different across the C825T genotype, (ii) no clustering of risk factors was detectable across the polymorphism, 41 and (iii) adjustment for confounders did not modify the association. Similarly, Semplicini et al. found that the 825T allele of GNB3 gene was associated with increased left ventricular mass independent of blood pressure and other risk factors, acting as an independent genetic marker. 42 Specific clinical history reduced the prognostic impact of the TT genotype, as adjusting for the number of historical CE made the association between this polymorphism and incident fatal CE less significant. Interestingly, no association of the C825T polymorphism with coronary events or with heart failure was found, suggesting a possible specificity of TT genotype for CE.
Although data on carotid ultrasound were not available in the present study, Bhuyian et al. found no association between the C825T polymorphism of GNB3 gene and carotid intimamedia thickness. 43 In summary, the 825T homozygosis of the GNB3 gene is significantly and independently associated with increased risk of incident CE in general population. Carrying the TT genotype exposes to additional risk of CE independent of blood pressure values and other established risk factors of stroke. TT homozygotes therefore deserve special clinical attention and need early identification and dedicated resources. Determination of C825T polymorphism should be taken into consideration in epidemiological studies dealing with stroke, as carrying the TT genotype can influence cerebrovascular mortality and morbidity, other conditions being equal. Further comprehensive genomic studies will be necessary to identify and localize other genes involved in susceptibility to cardiovascular complications. Further studies are needed to clarify the nature and pathways of this association.
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